Josephine Dietrich

Josephine Dietrich is a Senior Manager and Scientist at AvenCell since January 2022, following the company's rebranding from GEMoaB GmbH, where Dietrich served as an Associate Scientist from April 2020 to January 2022. Prior experience includes roles as a PhD Student and Master-Student at Cellex Patient Treatment focusing on immune checkpoint ligands and T cell redirection, respectively, as well as research internships at institutions such as the Center for Regenerative Therapies Dresden and OncoRay, where projects revolved around immunology and radiation oncology. Dietrich holds a Master of Science in Regenerative Biology and Medicine from Technische Universität Dresden and a Bachelor of Science in Biochemistry and Molecular Biology from Friedrich Schiller University Jena, along with experience in the Biology Department at the University of York.